Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Legitimate investigational retatrutide currently being studied in clinical trials has demonstrated a generally manageable short-term safety profile so far
You may be a good candidate for Semaglutide (GLP-1) or Tirzepatide (GLP-1/GLP-2) injections if: You have a BMI of 27 or higher with weight-related health concerns (such as high blood pressure, elevated cholesterol, or type 2 diabetes)
Pregnancy and breastfeeding are also contraindicated due to a lack of safety data for systemic use in these populations
The tirzepatide dosing schedule starts at 2.5mg weekly and escalates to a maximum of 15mg
US$ 23.30
US$ 28.71
US$ 28.83
US$ 21.47
US$ 29.78
/assets/images/provider/photos/2707250.jpeg)
